Latest DEF 14A proxy statements

InMed Pharmaceuticals Inc. announces its Annual General and Special Meeting on December 17, 2025, seeking shareholder approval for director elections, auditor reappointment, and a potential equity issuance of 20% or more of common shares.

BioCardia, Inc. announced its 2025 Annual Meeting of Stockholders will address the election of three Class III directors, an extension and amendment of its 2016 Equity Incentive Plan, and the ratification of its independent auditor.

Metsera, Inc. has issued a statement disagreeing with Pfizer's litigation allegations, vowing to address them in court.

Phunware, Inc. has filed definitive additional proxy materials related to its upcoming 2025 Annual General Meeting.

FG Nexus Inc. has filed a Definitive Proxy Statement with the U.S. Securities and Exchange Commission.

Workhorse Group Inc. is urging shareholders to vote in favor of its proposed merger with Motiv Power Systems, Inc. and all related proposals at its 2025 Annual Meeting to create long-term shareholder value in the medium-duty EV market.

NeoVolta, Inc. announced its 2025 Annual Meeting of Shareholders to be held on December 10, 2025, to vote on director elections and auditor ratification.

Tesla, Inc. has filed additional definitive proxy materials, including employee communications, Elon Musk's X posts, and website updates, related to its 2025 Annual Meeting of Shareholders.

The U.S. Department of Justice has issued a Second Request for additional information regarding the proposed merger between TEGNA Inc. and Nexstar Media Group, Inc., extending the regulatory review period.

Quantum Corporation announces its 2025 Annual Meeting of Shareholders to vote on director elections, convertible note exchanges, and an equity incentive plan amendment.

Wellgistics Health, Inc. announces the removal of two directors by majority shareholder consent and the appointment of four new directors, including a new President.

Stitch Fix, Inc. has filed a definitive additional materials proxy statement with the U.S. Securities and Exchange Commission.

WD-40 Company has filed a definitive proxy statement with the SEC, signaling upcoming shareholder matters.

Xenetic BioSciences, Inc. announced its 2024 Annual Meeting of Stockholders will be held virtually on December 11, 2024, to vote on director elections, auditor ratification, and executive compensation.

The Campbells Company issued a supplement to its 2025 proxy statement, clarifying director compensation oversight and defending Board Chair Keith R. McLoughlin's $350,000 annual retainer against an ISS recommendation.

Great Elm Group, Inc. filed an amendment to its 2025 Annual Stockholders Meeting proxy statement, updating committee compositions and proposing a new long-term incentive compensation plan.

Glucotrack, Inc. announced the adjournment of its Special Meeting of Stockholders from October 31, 2025, to November 7, 2025, with no changes to the record date or proposals.

Marwynn Holdings, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, to elect directors and ratify its accounting firm.

Epsilon Energy Ltd. has filed a supplement to its definitive proxy statement for the upcoming special meeting to approve the acquisition of Peak Exploration & Production and Peak BLM Lease, addressing shareholder demands and complaints regarding disclosure.

Microsoft Corporation filed a supplement to its 2025 proxy statement, clarifying the exclusion of two shareholder proposals due to procedural non-compliance and the impact of a government shutdown on SEC no-action processes.

ProPhase Labs seeks stockholder approval for a comprehensive digital asset and crypto treasury management strategy, alongside measures to maintain its Nasdaq listing, including a potential stock split.

FG Nexus Inc. announced its 2025 Annual Stockholders Meeting, revealing a net loss for 2024 and a significant decline in shareholder value amidst a strategic pivot to digital asset treasury strategies.

Phunware, Inc. announced its 2025 Annual Meeting agenda, including director elections and auditor ratification, while disclosing a legal dispute with a former director and internal control weaknesses.

Quantum Corporation is seeking shareholder approval for a critical debt restructuring plan involving convertible notes, a potential capital raise, and an amendment to its long-term incentive plan to address liquidity and operational flexibility.

Worksport Ltd. announces its 2025 Annual Meeting to address director elections, auditor ratification, and significant amendments to its equity incentive plan, following a year of massive revenue growth but substantial stock price decline.

The Marzetti Company has filed definitive additional proxy materials to update shareholders on outstanding equity awards ahead of its 2025 Annual Meeting.

WD-40 Company announces its 2025 Annual Meeting of Stockholders to be held virtually on December 12, 2025, focusing on director elections, executive compensation, and auditor ratification.

Stitch Fix, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 11, 2025, to elect directors, approve executive compensation, and ratify its independent auditor.

Xenetic Biosciences, Inc. announces its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and executive compensation.

PAVmed Inc. will hold a special meeting on December 5, 2025, to seek stockholder approval for a reverse stock split and a reduction in authorized common stock to regain Nasdaq compliance and attract institutional investors.